Profile Feature

Dr. Bulat Idrisov (above, left) is a National Institute on Drug Abuse (NIDA) International Program INVEST Drug Abuse Research Fellow under the mentorship of Dr. Jeffrey Samet, CHERISH HCV/HIV co-director. Dr. Idrisov completed his medical training in pediatrics and internal medicine in Russia and received a Fulbright Scholarship to complete his Master of Science in […]

Pilot grant awardee Dr. Karen Lasser and her team have developed an intervention to screen, link and treat patients with hepatitis C (HCV) in the primary care setting. As the founding medical director for HCV treatment in primary care, Dr. Lasser was motivated to do a budget impact analysis of their intervention to analyze whether the […]

The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]

University of Pennsylvania Assistant Professor of Emergency Medicine and LDI Senior Fellow Zachary Meisel, MD, has received a $2.1 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). The award will fund a 36-month comparative effectiveness study of enhanced opioid risk communication strategies for pain management following acute care. Meisel’s research team includes  LDI Senior Fellows Carolyn […]

Pilot grant awardee Dr. Yuhua Bao was invited to present her recent publication, “Prescription Drug Monitoring Programs Are Associated with Sustained Reductions in Opioid Prescribing by Physicians,” at the Health Affairs Issue Briefing on Behavioral Health in Washington, D.C on June 7, 2016. Dr. Bao’s presentation centered on her publication in the June 2017 issue of Health Affairs and is […]

The US Food and Drug Administration (FDA) recently issued new regulations for electronic nicotine delivery systems (ENDS) including vaporizers and e-cigarettes. The regulations will raise the purchasing age of ENDS to 18 years to align with cigarettes, require all ENDS manufacturers to submit chemical and manufacturing information for FDA review, which will result in new […]

Kit Delgado, MD, MS Dr. Delgado’s pilot grant will assess physician-level variability in opioid drug prescribing practices for six specific diagnoses across multiple specialties. Dr. Delgrado will use the Optum Cliniformatics DataMart national private insurance claims database to estimate excess prescription opioids prescribed by state and nationally, and calculate the resulting excess cost to the […]

CHERISH director Dr. Bruce Schackman presented at the National Drug Abuse Treatment Clinical Trials Network (CTN) Annual Scientific Meeting on April 12, 2016. The CTN is a NIDA-funded multi-site research project to determine the effectiveness of behavioral, pharmacological, and integrated treatment interventions across a broad range of community-based treatment settings and diversified patient populations. Dr. Schackman’s presentation […]

Dr. Alysse Wurcel is an infectious disease specialist and faculty member at Tufts University School of Medicine with a focus in HIV and hepatitis C (HCV) infection whose research interests closely align with her clinical work. Dr. Wurcel’s research is focused on the treatment of HCV in people who inject drugs (PWID), people in the criminal […]

Dr. McCollister is an Associate Professor and Health Economist in the Department Public Health Sciences at the University Of Miami Miller School Of Medicine. She is the Co-Director of the CHERISH Methodology Core. This interview discusses her interest in substance use health economics and her most recent publication “Cost Effectiveness analysis of a continuing care […]

On December 8th, CHERISH Director Dr. Bruce Schackman, delivered a presentation at the NIDA-funded located at the New York University College of Nursing. CDUHR Co-director and CHERISH Center Advisory Board Member Dr. Sherry Deren welcomed Dr. Schackman, who presented an overview of the mission, goals, and organization of CHERISH. Dr. Schackman highlighted the Methodology Consultation service offered by CHERISH […]

The high costs of treating the more than 7 million people with a substance use disorder may be daunting to public and private payers. The costs of not treating them may be even higher, especially if you consider the costs of failing to screen for and treat HIV and hepatitis C in this population. Sorting […]